Success Stories: A Chinese Scientist Working in Analytical Chemistry Wins NIW Approval without RFE with Our Team’s Help
Client’s Testimonial:
“Thank you for your help with my NIW!”
On March 19th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Scientist in the Field of Analytical Chemistry (Approval Notice).
General Field: Analytical Chemistry
Position at the Time of Case Filing: Scientist
Country of Origin: China
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: March 19th, 2022
Processing Time: 5 months, 14 days
Case Summary:
“Recent contributions to analytical chemistry like those made by [the client] have established themselves as invaluable resources in alleviating the burdens of many prominent illnesses... [The client], through his work in this field, has made significant progress in our understanding of the way carbohydrates both affect and indicate the pathogenesis and treatment of various diseases. In this way, it is difficult to overstate the value of [client’s] work to the U.S.”
The statement is a small section of a letter written in support of an expert in the field of analytical chemistry. It comes from a set of 4 such letters issued for his benefit. It was these letters of recommendation that our team used to solidify the ground on which our client, a scientist from China, rested his National Interest Waiver (NIW) application. His proposed endeavor was to develop high-efficiency analysis methods for different diseases in order to advance novel treatments.
Our team while investigating him initially understood that his research advancing his proposed endeavor is of great importance because it is crucial for a greater understanding of the role carbohydrates play in biological systems and in disease and drug interactions. Thus, the steps taken to prove his national worth became predictable. Our team made a list of information that they had gathered and used them to write his petition:
- Due to its clear national importance, his research has in fact been supported with funding from the National Institutes of Health (NIH) through the National Heart, Lung, and Blood Institute.
- He has completed at least 8 reviews to date and thus is clearly seen as an expert in his field.
- His research has resulted in 17 peer-reviewed journal articles (3 of them first-authored and 4 of them co-first-authored).
- These publications have been cited a total of 125 times according to Google Scholar.
- He has pursued research directly related to his proposed endeavor of developing analysis methods for carbohydrate mechanisms in disease for 6 years.
- He plans to hold a position that is narrowly tailored to his unique skill set related to developing high-efficiency analysis methods for different diseases in order to advance novel treatments.